Business Strategy and Outlook
Magellan’s refined product pipelines are high-quality assets that have contributed to earnings stability as well as steady increases in distributions over time. As both supply and demand are remarkably steady over time, Magellan has been able to extract modest inflation-linked price increases. However, investment opportunities have been more limited in the refined products segment. As a result, Magellan has invested more than $5 billion largely elsewhere since 2010 and has built up a respectable but ultimately more volatile and lower-quality crude oil pipeline, which now contributes about a third of operating margin.While the competitive intensity of the new businesses is higher than the core refined product pipelines.
Magellan’s current growth capital program is expected to wind down in 2021 with only $80 million in planned expenditures given the difficult environment. In 2022, Morningstar analyst focus remains on capital allocation. Growth spending is expected to be minimal. With a newly expanded $1.5 billion unit buyback in place, the partnership has already bought back $750 million in units in 2020 and 2021. Asset sales have contributed with $271 million completed in 2021, and another $435 million awaiting regulatory approvals and expected to be completed in 2022.
Magellan Midstream Sees Stronger Volume Recovery in 2021, Expands Buyback Program
Magellan’s capital spending program remains quite muted, as it plans to spend $80 million in 2021 and $20 million in 2022 on growth projects presently, it has devoted much more capital toward buybacks recently. The partnership bought back $391 million in units during the quarter, wrapping up its $750 million program initiated in 2020. The board has added another $750 million in buybacks and extended the program to 2024. With the stock trading below our fair value estimate, Morningstar analyst view both the historical repurchases and future program as good capital allocation and supportive of our Exemplary capital allocation rating.
Financial Strength
Magellan remains among the most prudent managers of capital in our MLP coverage. Three factors support this partnership’s exceptional level of financial health. First, the lack of general partner sponsorship keeps Magellan’s cost of equity lower than peers. Second, conservative leverage (far below its maximum ratio of 4 times debt/EBITDA) has kept its cost of debt low and provided considerable flexibility in financing growth projects. Third, ample distribution coverage has allowed management to fully fund its growth initiatives through retained distributable cash flow without needing to tap equity markets.
Magellan was one of the first MLPs to buy out its general partner interests in 2010. Better aligning interest of its holders, the deal also lowered the partnership’s cost of equity capital. Its stable, largely contracted sources of revenue and low leverage relative to peers also support among the lowest cost of debt in the industry. Combined, this cost of capital advantage and low leverage allows Magellan to more opportunistically engage in growth initiatives. Magellan has about $1 billion in liquidity compared and no debt maturities until 2025. The firm has flexed capital spending as needed to address any financial issues.
Bulls Say
- Magellan has been highly discerning with regards to capital allocation and invested in a number of attractive projects at excellent prices.
- Magellan supplies more than 40% of the refined products to 7 of the 15 states it serves.
- Magellan only undertakes profitable butane blending opportunities when spreads warrant it, meaning this is a low-risk endeavour.
Company Profile
While Magellan’s capital spending program remains quite muted, as it plans to spend $80 million in 2021 and $20 million in 2022 on growth projects presently, it has devoted much more capital toward buybacks recently. The partnership bought back $391 million in units during the quarter, wrapping up its $750 million program initiated in 2020. The board has added another $750 million in buybacks and extended the program to 2024. With the stock trading below our fair value estimate, we view both the historical repurchases and future program as good capital allocation and supportive of our Exemplary capital allocation rating.
(Source: Morningstar)
General Advice Warning
Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.